Results 31 to 40 of about 21,772 (207)

Reovirus uses macropinocytosis-mediated entry and fast axonal transport to infect neurons.

open access: yesPLoS Pathogens, 2020
Several barriers protect the central nervous system (CNS) from pathogen invasion. Yet viral infections of the CNS are common and often debilitating. Understanding how neurotropic viruses co-opt host machinery to overcome challenges to neuronal entry and ...
Pavithra Aravamudhan   +6 more
doaj   +1 more source

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy

open access: yesViruses, 2021
Oncolytic reovirus preferentially targets and kills cancer cells via the process of oncolysis, and additionally drives clinically favorable antitumor T cell responses that form protective immunological memory against cancer relapse. This two-prong attack
Vishnupriyan Kumar   +2 more
doaj   +1 more source

Origin of Reovirus Oligo(A) [PDF]

open access: yesJournal of Virology, 1974
Reovirus contains about 1,200 molecules per virion of oligo(A) of chain length 10 to 15 nucleotides in addition to the 10 double-stranded genome segments. Virions purified from infected BHK, HeLa, or L cells had similar amounts of oligo(A) of the same composition, indicating that it is a virus-specific product.
C, Carter   +3 more
openaire   +2 more sources

Reovirus infection induces stabilization and up-regulation of cellular transcripts that encode regulators of TGF-β signaling. [PDF]

open access: yesPLoS ONE, 2018
Reovirus infection induces dramatic changes in host mRNA expression. We utilized oligonucleotide microarrays to measure cellular mRNA decay rates in mock- or reovirus-infected murine L929 cells to determine if changes in host mRNA expression are a ...
Liang Guo   +5 more
doaj   +1 more source

Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain.

open access: yesPLoS Pathogens, 2008
Apoptosis plays an important role in the pathogenesis of reovirus encephalitis. Reovirus outer-capsid protein mu1, which functions to penetrate host cell membranes during viral entry, is the primary regulator of apoptosis following reovirus infection ...
Pranav Danthi   +4 more
doaj   +1 more source

The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism

open access: yesMolecular Therapy: Oncolytics, 2020
Reovirus type 3 Dearing (reovirus) is a tumor-selective oncolytic virus currently under evaluation in clinical trials. Here, we report that the therapeutic efficacy of reovirus in head and neck squamous cell cancer can be enhanced by targeting the ...
Martin McLaughlin   +11 more
doaj   +1 more source

Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis

open access: yesPLoS Pathogens, 2022
Cholesterol homeostasis is required for the replication of many viruses, including Ebola virus, hepatitis C virus, and human immunodeficiency virus-1. Niemann-Pick C1 (NPC1) is an endosomal-lysosomal membrane protein involved in cholesterol trafficking ...
Paula Ortega-Gonzalez   +13 more
doaj   +2 more sources

Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants

open access: yesViruses, 2015
Viruses that specifically replicate in tumor over normal cells offer promising cancer therapies. Oncolytic viruses (OV) not only kill the tumor cells directly; they also promote anti-tumor immunotherapeutic responses.
Adil Mohamed   +2 more
doaj   +1 more source

Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Background T-cell-engaging CD3-bispecific antibodies (CD3-bsAbs) are promising modalities for cancer immunotherapy. Although this therapy has reached clinical practice for hematological malignancies, the absence of sufficient infiltrating T cells is a ...
Rob C Hoeben   +9 more
doaj   +1 more source

Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Oncolytic viruses reduce tumor burden in animal models and have generated promising results in clinical trials. However, it is likely that oncolytic viruses will be more effective when used in combination with other therapies.
Simon Gebremeskel   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy